Quantitative Systematic Strategies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quantitative Systematic Strategies’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,577	Closed	-$990K	–	439
2021 Q2	$990K	Sell	10,577 -14,926	-59%	-$1.37M	0.35%	69
2021 Q1	$2.35M	Sell	25,503 -15,437	-38%	-$1.3M	0.36%	65
2020 Q4	$3M	Buy	40,940 +16,829	+70%	+$1.25M	0.42%	55
2020 Q3	$1.87M	Sell	24,111 -12,623	-34%	-$869K	0.33%	87
2020 Q2	$2.04M	Buy	36,734 +13,640	+59%	+$584K	0.4%	59
2020 Q1	$684K	Buy	23,094 +5,678	+33%	+$192K	0.56%	55
2019 Q4	$630K	Buy	17,416 +8,214	+89%	+$252K	0.09%	293
2019 Q3	$251K	Sell	9,202 -3,768	-29%	-$97.4K	0.06%	367
2019 Q2	$312K	Buy	+12,970	New	+$329K	0.06%	327
2018 Q3	–	Sell	-10,375	Closed	-$172K	–	874
2018 Q2	$172K	Buy	+10,375	New	+$158K	0.03%	567
2016 Q2	–	Sell	-18,551	Closed	-$298K	–	573
2016 Q1	$298K	Buy	+18,551	New	+$325K	0.12%	205

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Quantitative Systematic Strategies's HZNP Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2021, closing a stake of 10,577 shares — an estimated $990K sold.

Quantitative Systematic Strategies first reported a position in HZNP in Q1 2016 and held it in 11 quarters. The position peaked at $3M in Q4 2020. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

Quantitative Systematic Strategies reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 10,577 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $990K.
Quantitative Systematic Strategies first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2016 and held it in 11 quarters.
Quantitative Systematic Strategies's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3M in Q4 2020.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.